← Back to Search

3D Ultrasound for Maternal-Fetal Bonding

N/A
Recruiting
Led By Megan Kalata, MD, MPH
Research Sponsored by Creighton University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age - Female 19-45 years of age
Be between 18 and 65 years old
Must not have
Is not fluent in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 minutes

Summary

This trial is testing whether 3D models of fetuses' faces help improve African-American women's mental health during pregnancy.

Who is the study for?
This trial is for African American women, aged 19-45, who are fluent in English and currently pregnant (between 26-31 weeks) with a single baby. They must have had a normal ultrasound at 20 weeks and not more than three ultrasounds before the study.
What is being tested?
The study tests if giving African American mothers a 3D printed model of their fetus' face from an ultrasound can improve parental attachment and reduce stress, anxiety, depression while promoting healthier lifestyle choices during pregnancy.
What are the potential side effects?
There are no direct medical side effects expected from participating in this trial as it involves non-invasive procedures like receiving a 3D printed model or picture of the fetus or completing questionnaires.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman aged between 19 and 45.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not fluent in English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Maternal Antenatal Attachment Scale (MAAS)
Maternal Anxiety
Maternal Depression
+1 more

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: 3d printed modelActive Control1 Intervention
Mother r is given 3D printed model of fetus' face
Group II: ControlActive Control1 Intervention
Standard of Care
Group III: PlaceboPlacebo Group1 Intervention
Mother is given printed picture of 3D ultrasound of fetus

Find a Location

Who is running the clinical trial?

Creighton UniversityLead Sponsor
126 Previous Clinical Trials
25,582 Total Patients Enrolled
Megan Kalata, MD, MPHPrincipal InvestigatorCreighton University

Media Library

3d printed model Clinical Trial Eligibility Overview. Trial Name: NCT05293795 — N/A
Maternal-Fetal Relationship Research Study Groups: 3d printed model, Placebo, Control
Maternal-Fetal Relationship Clinical Trial 2023: 3d printed model Highlights & Side Effects. Trial Name: NCT05293795 — N/A
3d printed model 2023 Treatment Timeline for Medical Study. Trial Name: NCT05293795 — N/A
~38 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top